NASDAQ
Aligos Therapeutics, Inc. (ALGS) has a current ratio of 3.90x as of Monday, May 25, 2026. This represents a 13.46% decrease compared to its 12-month average of 4.51x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.